日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Industries

Stem cells offer ray of hope for healthy future

By Alfred Romann in Seoul For China Daily (China Daily) Updated: 2014-06-23 07:08

Regenerative medicine sector needs more financial support from private investors

One of the most important and innovative pharmaceutical companies in Asia has its headquarters in a busy neighborhood of Seoul, nestled between insurance companies and banks, and not far from Seoul National University.

Medipost Co Ltd, launched in 2000 to research and develop stem cell and regenerative medicine products, has emerged as a leader in the space, both regionally and globally. It took a dozen years for the company to launch its first product commercially: Cartistem used to treat repair cartilages in the knee.

Between its founding and its first product launch, Medipost issued new shares six times and split its stock once. It generated some further revenue, mostly by storing umbilical cord blood, using the blood to transplant stem cells, and later by out-licensing products.

But that income was tiny compared to the cost of developing its drugs. Improbably, it managed to attract enough investors to keep going and growing.

That investment is now starting to pay off. Cartistem is just one of three stem cell products approved for sale in South Korea, and Medipost might be the only public company in the country with global ambitions.

"There are not many companies that can deal with global development in the pharmerging market," said Jay Lee, a senior director at Medipost, speaking at a conference in South Korea last month.

The "pharmerging" markets are the emerging markets for pharmaceutical products. China is possibly the biggest, but there are quite a few of them in the region including South Korea and much of the Association of Southeast Asian Nations.

Even Japan, despite its large economy, is considered an emerging market in some ways because it is often years before drugs developed elsewhere make their way down to patients there due to conservative regulations.

But much is changing in the region, particularly in South Korea and Japan. Both countries are embracing often-controversial research into regenerative medicine, including stem cells.

"There is an exceptional example of a new approach in Japan. They are looking very much, as in South Korea, to develop the stem cell space," says Dianne Jackson-Matthews, an Australia-based director at ERA Consulting Group.

For the time being, government support is driving the growth of this particular industry. Private or institutional investors are not yet convinced that taking a risk on a company developing a drug using science few people understand is worthwhile.

Stem cells offer ray of hope for healthy future

Stem cells offer ray of hope for healthy future

 Stem Cell Industrial Park under construction in Wenjiang  Medical experts call for effective stem cell treatment regulation

Previous Page 1 2 3 Next Page

Hot Topics

Editor's Picks
...
...
主站蜘蛛池模板: 成年人免费网站在线观看 | 亚洲在线视频免费观看 | 91麻豆国产精品 | 亚洲专区av| 欧美午夜精品一区二区三区 | 久久人人爽人人爽人人片亚洲 | 久久国内精品视频 | 国产视频大全 | 一区二区三区国产视频 | 夜夜爽天天干 | 欧美性大交 | 免费成人深夜蜜桃视频 | 国产成人精品毛片 | 毛片999| 一区二区三区三区在线 | 在线免费播放av | 日出水了好爽 | 国产人成在线 | 天天舔天天射 | 视频一区二区在线 | 美女网站色 | 欧美在线小视频 | 天天干天天草天天射 | 日韩一区二区三区不卡 | 亚洲福利视频一区 | 午夜黄色在线观看 | 免费一级大片 | 国产欧美三级 | 亚洲一区二区三区免费在线观看 | 中国黄色一级视频 | 黄色成年人视频 | 一级特黄视频 | 六月丁香色婷婷 | 亚洲一二三在线观看 | 精品视频一区二区三区 | 国产精品久久久久av | 福利视频在线 | 九九综合网 | 九九视频免费看 | 欧美午夜精品一区二区 | 成人精品av |